After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease
Xconomy
FEBRUARY 28, 2019
It’s the latest step in a fast-moving journey for the La Jolla, CA-based company, which raised about $65 million in an initial public offering in October just 19 months after its founding.
Let's personalize your content